Partnered with ICI World of Journals.
DOI is provided by the Crossref and all the manuscripts will be indexed in Crossref
1.1. Background: Esophageal Squamous Cell Carcinoma (ESCC) causes a great disease burden in China and its prognosis remains poor. The role of adjuvant therapy in ESCC is controversial. The exploration of adjuvant therapy may benefit the maturation of the treatment strategy of ESCC.
No Data Available